Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Mogamulizumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kyowa Kirin Expands POTELIGEO Access In Central, East Europe
    Kyowa Kirin Expands POTELIGEO Access In Central, East Europe

    30 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250130103033/en

    BUSINESSWIRE
    30 Jan 2025
    Share Share
    Kyowa Kirin`s Biologic Poteligeo Receives Suppl Approval in US
    Kyowa Kirin`s Biologic Poteligeo Receives Suppl Approval in US

    22 Jan 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761051

    FDA
    22 Jan 2025
    Share Share
    Kyowa Kirin Announces Positive Data For Mogamulizumab At EORTC 2024
    Kyowa Kirin Announces Positive Data For Mogamulizumab At EORTC 2024

    08 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241008612756/en

    BUSINESSWIRE
    08 Oct 2024
    Share Share
    Kyowa Kirin, NewBridge To Improve Rare Disease Medicine Access In MENA
    Kyowa Kirin, NewBridge To Improve Rare Disease Medicine Access In MENA

    08 Aug 2024

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/24701/kyowa-kirin-newbridge-pharma-to-improve-access-to-rare-diseases-medicines-across-mena.html

    BIOSPECTRUM ASIA
    08 Aug 2024
    Share Share
    Poland Approves POTELIGEO® Reimbursement For MF And SS
    Poland Approves POTELIGEO® Reimbursement For MF And SS

    31 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240731235221/en

    BUSINESSWIRE
    31 Jul 2024
    Share Share
    Kyowa Kirin Demonstrates Commitment to Real-world Evidence for POTELIGEO
    Kyowa Kirin Demonstrates Commitment to Real-world Evidence for POTELIGEO

    21 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230920145186/en

    BUSINESSWIRE
    21 Sep 2023
    Share Share